Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 1
1996 1
1998 2
1999 1
2000 7
2001 1
2002 1
2003 4
2004 3
2005 8
2006 3
2007 11
2008 8
2009 8
2010 12
2011 8
2012 10
2013 16
2014 10
2015 22
2016 20
2017 22
2018 17
2019 17
2020 20
2021 26
2022 31
2023 29
2024 20

Text availability

Article attribute

Article type

Publication date

Search Results

284 results

Results by year

Filters applied: . Clear all
Page 1
The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality.
Karlsen TH, Sheron N, Zelber-Sagi S, Carrieri P, Dusheiko G, Bugianesi E, Pryke R, Hutchinson SJ, Sangro B, Martin NK, Cecchini M, Dirac MA, Belloni A, Serra-Burriel M, Ponsioen CY, Sheena B, Lerouge A, Devaux M, Scott N, Hellard M, Verkade HJ, Sturm E, Marchesini G, Yki-Järvinen H, Byrne CD, Targher G, Tur-Sinai A, Barrett D, Ninburg M, Reic T, Taylor A, Rhodes T, Treloar C, Petersen C, Schramm C, Flisiak R, Simonova MY, Pares A, Johnson P, Cucchetti A, Graupera I, Lionis C, Pose E, Fabrellas N, Ma AT, Mendive JM, Mazzaferro V, Rutter H, Cortez-Pinto H, Kelly D, Burton R, Lazarus JV, Ginès P, Buti M, Newsome PN, Burra P, Manns MP. Karlsen TH, et al. Among authors: treloar c. Lancet. 2022 Jan 1;399(10319):61-116. doi: 10.1016/S0140-6736(21)01701-3. Epub 2021 Dec 2. Lancet. 2022. PMID: 34863359 Free article. Review. No abstract available.
Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework.
Day E, Hellard M, Treloar C, Bruneau J, Martin NK, Øvrehus A, Dalgard O, Lloyd A, Dillon J, Hickman M, Byrne J, Litwin A, Maticic M, Bruggmann P, Midgard H, Norton B, Trooskin S, Lazarus JV, Grebely J; International Network on Hepatitis in Substance Users (INHSU). Day E, et al. Among authors: treloar c. Liver Int. 2019 Jan;39(1):20-30. doi: 10.1111/liv.13949. Epub 2018 Sep 22. Liver Int. 2019. PMID: 30157316 Free PMC article. Review.
Elimination of hepatitis C virus infection among PWID: The beginning of a new era of interferon-free DAA therapy.
Grebely J, Bruneau J, Bruggmann P, Harris M, Hickman M, Rhodes T, Treloar C; International Network on Hepatitis in Substance Users; International Network on Hepatitis in Substance Users. Grebely J, et al. Among authors: treloar c. Int J Drug Policy. 2017 Sep;47:26-33. doi: 10.1016/j.drugpo.2017.08.001. Int J Drug Policy. 2017. PMID: 28888558 No abstract available.
Afterword.
Treloar C, Holt M. Treloar C, et al. Int J Drug Policy. 2017 Nov;49:171-172. doi: 10.1016/j.drugpo.2017.09.003. Epub 2017 Oct 10. Int J Drug Policy. 2017. PMID: 29030081 No abstract available.
Pleasure and drugs.
Holt M, Treloar C. Holt M, et al. Among authors: treloar c. Int J Drug Policy. 2008 Oct;19(5):349-52. doi: 10.1016/j.drugpo.2007.12.007. Epub 2008 Jan 29. Int J Drug Policy. 2008. PMID: 18234486 No abstract available.
Progress and remaining challenges to address hepatitis C, other infectious diseases, and drug-related harms to improve the health of people who use drugs.
Grebely J, Collins AB, Artenie AA, Sutherland R, Meyer JP, Barocas JA, Falade-Nwulia O, Cepeda JA, Cunningham EB, Hajarizadeh B, Lafferty L, Lazarus JV, Bonn M, Marshall AD, Treloar C. Grebely J, et al. Among authors: treloar c. Int J Drug Policy. 2021 Oct;96:103469. doi: 10.1016/j.drugpo.2021.103469. Epub 2021 Oct 2. Int J Drug Policy. 2021. PMID: 34610884 No abstract available.
A gender lens is needed in hepatitis C elimination research.
Larney S, Madden A, Marshall AD, Martin NK, Treloar C. Larney S, et al. Among authors: treloar c. Int J Drug Policy. 2022 May;103:103654. doi: 10.1016/j.drugpo.2022.103654. Epub 2022 Mar 17. Int J Drug Policy. 2022. PMID: 35306279
284 results